News

Neovacs and Lupus Europe Help Raise Awareness of the Disease on World Lupus Day

The French immunotherapy vaccine developer Neovacs joined with Lupus Europe to raise awareness of the disease on World Lupus Day yesterday. Neovacs develops vaccines for lupus and other autoimmune diseases. Lupus Europe is an umbrella organization of 24 patient associations in 22 countries. Paris-based Neovacs developed its proprietary Kinoid technology to target diseases associated…

Lupus Patients Should Have Their Heart Valves Checked, Researchers Say

Lupus patients should be checked for heart-valve abnormalities because the disease increases the risk of the heart condition, according to a study. Earlier research identified anti-phospholipid antibodies as a risk factor for this heart condition. The new study shows that systemic lupus erythematosus poses a risk in patients without the antibodies.

GSK Expands Maryland Plant to Manufacture SLE Therapy Benlysta for a Booming U.S. Market

Booming sales of Benlysta (belimumab) to treat adults with active, autoantibody-positive systemic lupus erythematosus (SLE) have led British pharmaceutical giant GlaxoSmithKline to invest $139 million in its manufacturing plant in Rockville, Maryland. The facility, which will expand the company’s bulk substance production by nearly 50 percent, will produce a new subcutaneous, self-injectable form…